Global Pharmaceuticals & Biotech Most Popular Stocks

Jolt Health

Market Cap: CA$1.1m

Operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada.

Waverley Pharma

Market Cap: CA$1.1m

A biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom.

Ovation Science

Market Cap: CA$1.1m

Engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States.

EGF Theramed Health

Market Cap: CA$1.0m

Engages in the development of psychedelic drugs for the treatment of mental health problems in Canada.

Pure Harvest Group

Market Cap: US$718.0k

Focuses on the acquisition and operation of licensed medical and recreational marijuana dispensaries, cultivation facilities, and production facilities.

LadRx

Market Cap: US$717.9k

A biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States.

Nutra Pharma

Market Cap: US$710.0k

A biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States.

Steep Hill

Market Cap: CA$970.7k

Does not have significant operations.

Neutra

Market Cap: US$690.2k

Researches, develops, and provides hemp-derived products in the nutraceutical space in the United States.

Emmaus Life Sciences

Market Cap: US$677.0k

A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.

Scorpius Holdings

Market Cap: US$672.6k

Through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization.

Vitalibis

Market Cap: US$670.8k

Operates as a technology-based formulator of phytocannabinoid rich hemp products with cannabidiol, along with personal care and nutritional products.

Cannabis Global

Market Cap: US$656.4k

Focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body.

HAVN Life Sciences

Market Cap: CA$859.4k

A biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi.

Maple Leaf Green World

Market Cap: US$624.0k

Does not have significant operations.

Kobo Biotech

Market Cap: ₹54.8m

Manufactures active pharmaceutical ingredients based on fermentation technology in India.

Lumiera Health

Market Cap: CA$849.8k

Develops and commercializes evidence-based botanical products for the healthcare in Canada.

Hepion Pharmaceuticals

Market Cap: US$615.8k

A biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States.

Lophos Holdings

Market Cap: CA$858.6k

Through its subsidiaries, engages in the cultivation and research of peyote cactus.

Sybleu

Market Cap: US$583.7k

SYBLEU INC. intends to engage in the primarily in the acquisition, licensing, and development of regenerative medical applications.

Fabino Enterprises

Market Cap: ₹50.9m

Manufactures, markets, trades, and packages pharmaceutical and other wellness focused consumer products in India.

Bio-Path Holdings

Market Cap: US$531.4k

Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.

Pharmagreen Biotech

Market Cap: US$530.9k

Operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America.

Innovation Pharmaceuticals

Market Cap: US$528.8k

A clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective.

Maven Brands

Market Cap: CA$702.8k

Together with its subsidiary, engages in the production, toll-processing, and packaging of medical cannabis in Canada.

Nirvana Life Sciences

Market Cap: CA$684.7k

Engages in the research and development of therapeutic products and medicines to address addiction.

Aequus Pharmaceuticals

Market Cap: CA$663.2k

Operates as a specialty pharmaceutical company in Canada.

Regen BioPharma

Market Cap: US$469.8k

Focuses on the development of regenerative medical applications in the United States.

Grapefruit USA

Market Cap: US$464.8k

Operates as a manufacturer and distributor of cannabis products in California.

Itonis

Market Cap: US$457.0k

A development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases.

NDT Pharmaceuticals

Market Cap: US$453.1k

A biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury.

Sangui Biotech International

Market Cap: €419.8k

Through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products.

MPS Pharmaa

Market Cap: ₹38.0m

Manufactures, markets, trades in, and exports pharmaceutical products in India and internationally.

TC Biopharm (Holdings)

Market Cap: US$420.6k

A clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States.

Hemo Organic

Market Cap: ₹36.7m

Engages in the buying, selling, reselling, importing, exporting, transporting, storing, developing, promoting, supplying, marketing, and dealing of the agricultural products in India and internationally.

Biome Grow

Market Cap: CA$562.1k

Focuses on the cannabis business.